Team:EPF-Lausanne/Our Project/Summary

From 2011.igem.org

(Difference between revisions)
Line 39: Line 39:
This is the ''in vitro'' characterization, which was performed thank to a microfluidic chip. This technique, called MITOMI, allows parallel testing of one mutant with 756 different DNA sequences. The absolute binding energy is then measured, and an enoLOGO is generated.
This is the ''in vitro'' characterization, which was performed thank to a microfluidic chip. This technique, called MITOMI, allows parallel testing of one mutant with 756 different DNA sequences. The absolute binding energy is then measured, and an enoLOGO is generated.
 +
 +
[[File:EPFL-MITOMI shot.png|400px]]
''' 3) determining the binding of each mutant to the wild-type TetO sequence ''in vivo''
''' 3) determining the binding of each mutant to the wild-type TetO sequence ''in vivo''

Revision as of 19:54, 28 October 2011